HIGH POINT, N.C.--(BUSINESS WIRE)--Mar. 10, 2017--
vTv Therapeutics Inc. (vTv) (Nasdaq: VTVT), a clinical-stage
biopharmaceutical company engaged in the discovery and development of
new orally administered treatments for Alzheimer’s disease and diabetes,
among other therapeutic areas, today announced that company management
will present a corporate overview at two upcoming investor conferences.
ROTH Capital Partners 29th Annual Growth Stock
Location: Dana Point, California
Presentation Date: Tuesday, March 14, 2017
Presentation Time: 7:30 am PT
Needham & Co. 16th Annual Healthcare Conference
Location: New York, New York
Presentation Date: Tuesday, April 4, 2017
Presentation Time: 4:20 pm ET
Live webcasts of the presentations can be accessed on the News
& Events section of the website. The webcasts will be archived
for 30 days following the presentations on the Company’s website at www.vtvtherapeutics.com.
About vTv Therapeutics
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company
engaged in the discovery and development of orally administered small
molecule drug candidates to fill significant unmet medical needs. vTv
has a pipeline of clinical drug candidates led by programs for the
treatment of Alzheimer’s disease and Type 2 diabetes as well as
treatment of inflammatory disorders and the prevention of muscle
View source version on businesswire.com: http://www.businesswire.com/news/home/20170310005614/en/
Source: vTv Therapeutics Inc.
vTv Therapeutics Inc.
Michael Gibralter, 646-378-2938
Katie Engleman, 910-509-3977